96 related articles for article (PubMed ID: 11290866)
1. Selection of candidates for oral etoposide salvage chemotherapy in heavily pretreated breast cancer patients.
Jagodic M; Cufer T; Zakotnik B; Cervek J
Anticancer Drugs; 2001 Mar; 12(3):199-204. PubMed ID: 11290866
[TBL] [Abstract][Full Text] [Related]
2. Daily oral etoposide in patients with heavily pretreated metastatic breast cancer.
Pusztai L; Walters RS; Valero V; Theriault RL; Hortobagyi GN
Am J Clin Oncol; 1998 Oct; 21(5):442-6. PubMed ID: 9781596
[TBL] [Abstract][Full Text] [Related]
3. Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series.
Giannone G; Milani A; Ghisoni E; Genta S; Mittica G; Montemurro F; Valabrega G
Breast; 2018 Apr; 38():160-164. PubMed ID: 29413403
[TBL] [Abstract][Full Text] [Related]
4. A retrospective analysis of the activity and safety of oral Etoposide in heavily pretreated metastatic breast cancer patients.
Valabrega G; Berrino G; Milani A; Aglietta M; Montemurro F
Breast J; 2015; 21(3):241-5. PubMed ID: 25772707
[TBL] [Abstract][Full Text] [Related]
5. 21-day oral etoposide for metastatic breast cancer: a phase II study and review of the literature.
Saphner T; Weller EA; Tormey DC; Pandya KJ; Falkson CI; Stewart J; Robert NJ
Am J Clin Oncol; 2000 Jun; 23(3):258-62. PubMed ID: 10857889
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of oral Etoposide in pretreated metastatic breast cancer: a multicenter phase 2 study.
Yuan P; Di L; Zhang X; Yan M; Wan D; Li L; Zhang Y; Cai J; Dai H; Zhu Q; Hong R; Xu B
Medicine (Baltimore); 2015 May; 94(17):e774. PubMed ID: 25929919
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of oral etoposide for patients with advanced breast cancer.
Atienza DM; Vogel CL; Trock B; Swain SM
Cancer; 1995 Dec; 76(12):2485-90. PubMed ID: 8625074
[TBL] [Abstract][Full Text] [Related]
8. A phase II trial of mitomycin C, 5'-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor action.
Kim R; Osaki A; Tanabe K; Kojima J; Toge T
Oncol Rep; 2001; 8(3):597-603. PubMed ID: 11295087
[TBL] [Abstract][Full Text] [Related]
9. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.
Souhami RL; Spiro SG; Rudd RM; Ruiz de Elvira MC; James LE; Gower NH; Lamont A; Harper PG
J Natl Cancer Inst; 1997 Apr; 89(8):577-80. PubMed ID: 9106647
[TBL] [Abstract][Full Text] [Related]
10. Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes.
Kalbakis K; Kouroussis C; Kakolyris S; Mavroudis D; Souglakos J; Agelaki S; Vamvakas L; Christodoulakis M; Stylianou K; Georgoulias V
Br J Cancer; 2001 Sep; 85(6):798-802. PubMed ID: 11556827
[TBL] [Abstract][Full Text] [Related]
11. A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
Karachaliou N; Ziras N; Syrigos K; Tryfonidis K; Papadimitraki E; Kontopodis E; Bozionelou V; Kalykaki A; Georgoulias V; Mavroudis D
Cancer Chemother Pharmacol; 2012 Jul; 70(1):169-76. PubMed ID: 22669571
[TBL] [Abstract][Full Text] [Related]
12. Clinical activity of chronic oral etoposide in previously treated metastatic breast cancer.
Martín M; Lluch A; Casado A; Santabárbara P; Adrover E; Valverde JJ; López-Martín JA; Rodriguez-Lescure A; Azagra P; García-Conde J
J Clin Oncol; 1994 May; 12(5):986-91. PubMed ID: 8164052
[TBL] [Abstract][Full Text] [Related]
13. Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens.
Cabel L; Carton M; Cheaib B; Pierga JY; Dalenc F; Mailliez A; Levy C; Jacot W; Debled M; Leheurteur M; Desmoulins I; Lefeuvre C; Gonçalves A; Uwer L; Ferrero JM; Eymard JC; Petit T; Mouret-Reynier MA; Perrocheau G; Piot I; Pérol D; Simon G; Lerebours F
Breast Cancer Res Treat; 2019 Jan; 173(2):397-406. PubMed ID: 30357526
[TBL] [Abstract][Full Text] [Related]
14. Daily oral etoposide in metastatic breast cancer.
Nesković-Konstantinović ZB; Bosnjak SM; Radulović SS; Mitrović LB
Anticancer Drugs; 1996 Jul; 7(5):543-7. PubMed ID: 8862722
[TBL] [Abstract][Full Text] [Related]
15. Salvage therapy with oral etoposide in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gedlicka C; Kornfehl J; Turhani D; Burian M; Formanek M
Cancer Invest; 2006; 24(3):242-5. PubMed ID: 16809151
[TBL] [Abstract][Full Text] [Related]
16. Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study.
Steger GG; Dominguez A; Dobrovolskaya N; Giotta F; Tubiana-Mathieu N; Pecherstorfer M; Ardizzoia A; Blasinska-Morawiec M; Espinosa E; Villanova G
Clin Breast Cancer; 2018 Feb; 18(1):e41-e47. PubMed ID: 28666812
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.
Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V
Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644
[TBL] [Abstract][Full Text] [Related]
18. Oral etoposide monotherapy is effective for metastatic breast cancer with heavy prior therapy.
Yuan P; Xu BH; Wang JY; Ma F; Fan Y; Li Q; Zhang P
Chin Med J (Engl); 2012 Mar; 125(5):775-9. PubMed ID: 22490573
[TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.
Evans SR; Krown SE; Testa MA; Cooley TP; Von Roenn JH
J Clin Oncol; 2002 Aug; 20(15):3236-41. PubMed ID: 12149296
[TBL] [Abstract][Full Text] [Related]
20. Preliminary results of a phase II trial of chronic oral etoposide in breast cancer.
Martín M; Casado A; Lluch A; Adrover E; Diaz-Rubio E; García-Conde J
Cancer Treat Rev; 1993; 19 Suppl C():47-52. PubMed ID: 8221716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
